Median difference between peritoneal fluid and serum concentrations of sHLA-G in ovarian cancer patients (21.2 U/ml) turned out to be significantly higher than in women with benign serous cysts (13.04 U/ml) and endometrioma (13.00 U/ml) (Fig. 1). This evidence concerns the gene HLA-G and ovarian cancer.